{"id":"W2083461538","doi":"10.1016/j.ygyno.2014.06.033","title":"Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Fraser Health; Interior Health; Princess Margaret Cancer Centre; University of the Fraser Valley; Hamilton Health Sciences; University Health Network; University of Toronto; McGill University","funders":"","keywords":"Medicine; Tolerability; Endometrial cancer; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Angiogenesis; Protein kinase B; Cancer research; Cancer; Adverse effect; Signal transduction; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024566,0.00115565,0.002474237,0.0005287378,0.0004259757,0.0008111016,0.0008928381,0.001333359,0.004245998],"category_scores_gemma":[0.0007465147,0.0006747539,0.00118742,0.0004204846,0.001164697,0.0006560536,0.0003091407,0.002575113,0.0008827557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006514756,"about_ca_system_score_gemma":0.001594541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002014826,"about_ca_topic_score_gemma":0.005191119,"domain_scores_codex":[0.9996805,0.0001411659,0.00001235613,0.00005129078,0.00001773725,0.00009685677],"domain_scores_gemma":[0.9995859,0.0000787575,0.00005188285,0.00004965515,0.00001776635,0.0002161305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7188178,0.06377263,0.006373894,0.0013033,0.001480735,0.0002990267,0.0004540877,0.00309233,0.04345146,0.00058404,0.005249647,0.1551211],"study_design_scores_gemma":[0.4906523,0.4910448,0.007372295,0.00004229898,0.0007066868,0.0002263066,0.0001593701,0.0009422036,0.003596905,0.0002970496,0.004923655,0.00003610537],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884651,0.003872413,0.0006688572,0.0009186929,0.0002481072,0.002019457,0.001287429,0.0001379932,0.002381844],"genre_scores_gemma":[0.9825608,0.003820977,0.001740691,0.001138476,0.0002336018,0.00255621,0.002041659,0.00004412289,0.005863379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004245998,"threshold_uncertainty_score":0.01420426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03870914564415043,"score_gpt":0.3676299882226336,"score_spread":0.3289208425784831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}